How much funding has ONCOSTING, LLC raised?

ONCOSTING, LLC has raised $2.6M in total funding, most recently a grant round.

Who are ONCOSTING, LLC's investors?

ONCOSTING, LLC's investors include National Institute on Aging.

When was ONCOSTING, LLC founded?

ONCOSTING, LLC was founded in 2021.

Where is ONCOSTING, LLC headquartered?

ONCOSTING, LLC is headquartered in BALTIMORE, Maryland, United States.

What industry is ONCOSTING, LLC in?

ONCOSTING, LLC operates in Biotech, Healthcare.

How many employees does ONCOSTING, LLC have?

ONCOSTING, LLC has 1-10 employees.

ONCOSTING, LLC

BALTIMORE, United States · Founded 2021 · $2.6M raised

Biotech

Healthcare

Headquarters: BALTIMORE, Maryland
Employees: 1–10
Founded: 2021
Business Model: B2B

Total Funding: $2.6M
Last Round: $2.6M GrantSep 2021
Rounds: 1

About

OncoSTING is a biotechnology company developing recombinant BCG immunotherapies that overexpress STING agonists for the treatment of non-muscle-invasive bladder cancer and tuberculosis. Its lead candidates OS-101 and OS-151 are engineered to enhance anti-tumor and anti-TB immune responses via the innate immune STING-IRF3-NF-κB pathway. The company has received NIH and NSF SBIR/STTR funding totaling over $3.7M.

Summary

ONCOSTING, LLC is a Biotech company based in BALTIMORE, United States, founded in 2021. It has raised $2.6M in total across 1 round, most recently a $2.6M Grant round in Sep 2021. Investors include National Institute on Aging.